Rates of Antidepressant, Anxiolytic, and ADHD Medication Use Among Patients Undergoing ESS
Patients with chronic rhinosinusitis (CRS) are estimated to have psychiatric comorbidity at a higher rate than the general population; however, self-report of depression diagnoses or symptoms often underestimates true prevalence in many populations. In the present study, a cohort of 2279 patients undergoing endoscopic sinus surgery (ESS) were matched to an equal number of non-CRS control subjects by age, sex, race and health status. Overall, the rate of antidepressant/anxiolytic utilization among ESS patients was 22.1%versus 11.3% for controls (P < .001, OR = 2.23, 95% CI 1.90-2.63). The rate of ADHD medication utilization among ESS patients was 3.6%versus 2.0% for controls (P = .001, OR = 1.85, 95% CI 1.28-2.68). This study suggests that patients undergoing ESS exhibit significantly higher rates of antidepressant and ADHD medication utilization relative to a matched control population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:132 |
|---|---|
| Enthalten in: |
The Annals of otology, rhinology, and laryngology - 132(2023), 12 vom: 02. Dez., Seite 1679-1681 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Workman, Alan D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ADHD |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 23.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/00034894231179016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357711130 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357711130 | ||
| 003 | DE-627 | ||
| 005 | 20231226073200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/00034894231179016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1192.xml |
| 035 | |a (DE-627)NLM357711130 | ||
| 035 | |a (NLM)37269081 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Workman, Alan D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rates of Antidepressant, Anxiolytic, and ADHD Medication Use Among Patients Undergoing ESS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 23.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Patients with chronic rhinosinusitis (CRS) are estimated to have psychiatric comorbidity at a higher rate than the general population; however, self-report of depression diagnoses or symptoms often underestimates true prevalence in many populations. In the present study, a cohort of 2279 patients undergoing endoscopic sinus surgery (ESS) were matched to an equal number of non-CRS control subjects by age, sex, race and health status. Overall, the rate of antidepressant/anxiolytic utilization among ESS patients was 22.1%versus 11.3% for controls (P < .001, OR = 2.23, 95% CI 1.90-2.63). The rate of ADHD medication utilization among ESS patients was 3.6%versus 2.0% for controls (P = .001, OR = 1.85, 95% CI 1.28-2.68). This study suggests that patients undergoing ESS exhibit significantly higher rates of antidepressant and ADHD medication utilization relative to a matched control population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ADHD | |
| 650 | 4 | |a anxiety | |
| 650 | 4 | |a chronic rhinosinusitis | |
| 650 | 4 | |a depression | |
| 650 | 4 | |a endoscopic sinus surgery | |
| 650 | 4 | |a psychiatry | |
| 650 | 7 | |a Anti-Anxiety Agents |2 NLM | |
| 700 | 1 | |a Dattilo, Lillian W |e verfasserin |4 aut | |
| 700 | 1 | |a Mitchell, Margaret B |e verfasserin |4 aut | |
| 700 | 1 | |a Rathi, Vinay K |e verfasserin |4 aut | |
| 700 | 1 | |a Bhattacharyya, Neil |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Annals of otology, rhinology, and laryngology |d 1945 |g 132(2023), 12 vom: 02. Dez., Seite 1679-1681 |w (DE-627)NLM000056952 |x 1943-572X |7 nnns |
| 773 | 1 | 8 | |g volume:132 |g year:2023 |g number:12 |g day:02 |g month:12 |g pages:1679-1681 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/00034894231179016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 132 |j 2023 |e 12 |b 02 |c 12 |h 1679-1681 | ||